180 related articles for article (PubMed ID: 14703723)
1. Assessing immunotoxicity: guidelines.
Putman E; van der Laan JW; van Loveren H
Fundam Clin Pharmacol; 2003 Oct; 17(5):615-26. PubMed ID: 14703723
[TBL] [Abstract][Full Text] [Related]
2. Regulatory aspects of immunotoxicology.
Schulte A; Ruehl-Fehlert C
Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
[TBL] [Abstract][Full Text] [Related]
3. A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements.
Giannakou C; Park MV; de Jong WH; van Loveren H; Vandebriel RJ; Geertsma RE
Int J Nanomedicine; 2016; 11():2935-52. PubMed ID: 27382281
[TBL] [Abstract][Full Text] [Related]
4. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
[TBL] [Abstract][Full Text] [Related]
5. US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins.
Hinton DM
Toxicol Pathol; 2000; 28(3):467-78. PubMed ID: 10862567
[TBL] [Abstract][Full Text] [Related]
6. Implications of the new FDA/CDER immunotoxicology guidance for drugs.
Hastings KL;
Int Immunopharmacol; 2002 Oct; 2(11):1613-8. PubMed ID: 12433062
[TBL] [Abstract][Full Text] [Related]
7. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
Spanhaak S
Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two guidelines on immunotoxicity testing of medicinal products.
Dujmović IH
Arh Hig Rada Toksikol; 2005 Sep; 56(3):265-8. PubMed ID: 16180612
[TBL] [Abstract][Full Text] [Related]
9. Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk.
Dietert RR
Curr Drug Saf; 2008 Sep; 3(3):216-26. PubMed ID: 18691005
[TBL] [Abstract][Full Text] [Related]
10. Immune function testing of human pharmaceuticals: regulatory overshoot?
van der Laan JW; van Loveren H
Expert Opin Drug Saf; 2005 Jan; 4(1):1-5. PubMed ID: 15709893
[TBL] [Abstract][Full Text] [Related]
11. Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
Collinge M; Burns-Naas LA; Chellman GJ; Kawabata TT; Komocsar WJ; Piccotti JR; Shenton J; Wierda D
J Immunotoxicol; 2012; 9(2):210-30. PubMed ID: 22428536
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxicology: role in the safety assessment of drugs.
Descotes J
Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
[TBL] [Abstract][Full Text] [Related]
13. A brief history of immunotoxicology and a review of the pharmaceutical guidelines.
Dean JH
Int J Toxicol; 2004; 23(2):83-90. PubMed ID: 15204726
[TBL] [Abstract][Full Text] [Related]
14. How to predict adverse immune reactions induced by pharmaceutical compounds.
Goldman M; Miller K; Bazin H
Trends Biotechnol; 1995 Aug; 13(8):283-5. PubMed ID: 7662302
[No Abstract] [Full Text] [Related]
15. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective.
Descotes J
Toxicol Lett; 2004 Apr; 149(1-3):103-8. PubMed ID: 15093254
[TBL] [Abstract][Full Text] [Related]
16. [Immunotoxicity assessment in the preclinical study of biologically active compounds].
Uteshev BS; Arzamastsev EV
Eksp Klin Farmakol; 1996; 59(3):3-8. PubMed ID: 8974580
[TBL] [Abstract][Full Text] [Related]
17. Toxicopathology of the developing immune system: investigative and development strategies.
Weinstock D; Lewis DB; Parker GA; Beyer J; Collinge M; Brown TP; Dybdal N
Toxicol Pathol; 2010 Dec; 38(7):1111-7. PubMed ID: 20962107
[TBL] [Abstract][Full Text] [Related]
18. Immunobiology of zinc and zinc therapy.
Reinhold D; Ansorge S; Grüngreiff K
Immunol Today; 1999 Feb; 20(2):102-3. PubMed ID: 10098330
[No Abstract] [Full Text] [Related]
19. [Review on requirements of drug allergy or pseudoallergic reactions in pre-clinical evaluation].
Han JY; Yi Y; Liang AH; Zhang YS; Li CY; Zhao Y; Wang LM; Lu YT; Li GQ
Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2685-9. PubMed ID: 26666009
[TBL] [Abstract][Full Text] [Related]
20. Molecular and cellular basis of chemically induced immunotoxicity.
Luster MI; Blank JA; Dean JH
Annu Rev Pharmacol Toxicol; 1987; 27():23-49. PubMed ID: 3555316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
